Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis-associated protein 2-like (SPATA2L) is a member of the SPATA protein family, designated by homology to SPATA2, a protein involved in testis development and spermatogenesis[4]. SPATA2L is encoded by the C16orf76 gene. According to publicly available protein expression databases, SPATA2L is expressed in a range of tissues and cell types, but its precise molecular function remains uncharacterized. There is no evidence to suggest SPATA2L acts as a receptor, enzyme, or recognized therapeutic target. It is distinct from SPATA2, which has known roles in spermatogenesis and TNF signaling. Scientific literature still lacks definitive information regarding the biological or pathological roles, relevance as a biomarker, or association with drug mechanisms for SPATA2L.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 2-like (SPATA2L).